Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

View Xia Zhenya’s artworks on artnet. Learn about the artist and find an in-depth biography, exhibitions, original artworks, the latest news, and sold auction prices. Price Database ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.